Vitrectomy Devices Market Size, Share & Trends Analysis Report By Product, By Application (Diabetic Retinopathy, Retinal Detachment), By End-use (Hospitals, Ambulatory Surgical Centers), By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The global vitrectomy devices market size was exhibited at USD 1,037.50 million in 2023 and is projected to hit around USD 1,929.32 million by 2033, growing at a CAGR of 6.4% during the forecast period of 2024 to 2033.

Key Takeaways:

• The vitrectomy machines segment dominated the market and held the largest revenue share of 36.9% in 2023.
• The macular hole segment dominated the market and held the largest revenue share of 25.3% in 2023.
• The hospital segment dominated the market and held the largest revenue share of around 43.0% in 2023.
• North America dominated the market and accounted for the largest revenue share of 37.0% in 2023.

Vitrectomy Devices Market Report Scope

Vitrectomy helps in clearing out the blood from the vitreous humor and in preventing traction retinal detachment. This, in turn, smooths the process of other ophthalmic surgeries and avoids further detachment of the retina during the same. Additionally, vitrectomy also helps in restoring vision loss caused by bleeding of the vitreous humor.

The growing prevalence of retinal disease and the factors causing the disease are expected to drive the market growth during the forecast period. Diabetes has a negative impact on eye health, leading to vision loss by impacting the blood vessels of the retina. As per National Eye Institute, in 2018, around 7.7 million Americans had diabetic retinopathy. This number is expected to increase and reach 11.3 million by 2030, thus, propelling market growth during the forecast period.

The outbreak of COVID-19 has negatively impacted various medical practices, including ophthalmology. It has been observed that conjunctivitis develops in around 1% to 3% of people with coronavirus. Hence, to reduce the spread of the infection, ophthalmologists are being urged not to conduct ophthalmic surgeries during the pandemic except for emergency care. Various end-users in different regions are experiencing a decrease in ophthalmic surgeries, such as vitrectomy. However, the government is taking initiatives and providing guidelines to ease the adoption of medical care including ophthalmic surgeries like vitrectomy during the pandemic, which is thus, expected to boost the growth of the market during the forecast period.

As per the NCBI article published in July 2021, hospital admissions for rhegmatogenous retinal detachment (RRD) is increasing in the U.K. since 2000. As per HES Hospital Admitted Patient Care Activity records, a large number of patients is admitted for RRD, which in turn is driving the demand for pars plana vitrectomy procedures. Therefore, to meet the growing demand, market players are showcasing advancements made in retina space in conferences to increase its reach and adoption. For instance, in July 2019, Alcon showcased its new Dual Blade Vitrectomy Probe, HYPERVIT, at the American Society of Retina Specialists 2019 annual meeting. This new advanced probe is designed to enhance control and stability during microincision vitrectomy surgery.

Apart from the various advantages associated with vitrectomy surgery and devices, the risks associated with the process are expected to pose a threat to its adoption. The possible risks associated with vitrectomy include infection in the eye, bleeding in the vitreous gel, retinal detachments, and high intraocular pressure. In addition to this, patients might develop cataracts or other eye problems after few years of vitrectomy.

Product Insights

The vitrectomy machines segment dominated the market and held the largest revenue share of 36.8% in 2023. The growth of the segment can be attributed to the development of new generation machines with advanced features such as improvised fluidics, high cut rates, small gauge size, and intraocular pressure control. For instance, Alcon’s Constellation Vision System has fluidics that works for small-gauge surgery, thus overcoming the limitations of previous machines.

The vitrectomy pack segment is expected to grow at the fastest rate during the forecast period. This can be attributed to the increased adoption of these packs in a wide range of indications, such as the removal of vitreous from the retina, the removal of the epiretinal membrane, collective procedures for retinal surgery, and the detachment of posterior vitreous. Moreover, additional benefits of the vitrectomy pack, such as high portability, optical magnification, and high sensitivity, are expected to boost the market for vitrectomy devices.

The photocoagulation lasers segment also held a significant revenue share in the market for vitrectomy devices in 2023. Laser photocoagulation surgery helps in shrinking or destroying abnormal retina structures and hence is widely adopted for correcting retina-related conditions such as diabetic retinopathy. As per CDC, the prevalence of diabetic retinopathy is high and affects one-third of African-Americans and Mexican Americans aged 40 years. In addition, 4.2 million people suffer from diabetic retinopathy, and 655,000 people suffer from vision-threatening diabetic retinopathy. Thus, the growing prevalence of diabetic retinopathy is expected to propel segment growth during the forecast period.

Application Insights

The macular hole segment dominated the market and held the largest revenue share of 25.2% in 2023. The segment is expected to grow at a significant rate. A macular hole is a small breakage in the macula, located in the center of the retina. The interior of the eye is filled with a vitreous gel-like substance. As we age, this gel starts to shrink slowly and pulls away from the retinal surface. During this time it may tear the retina or result in a macular hole. Few macular holes heal themselves; however, most of them require surgery called vitrectomy to improve vision. Additionally, a macular hole can also occur due to high myopia, eye injury, and retinal detachment. Therefore, the growing prevalence of these diseases is expected to boost segment growth.

The retinal detachment segment is expected to experience the fastest growth during the forecast period. Retinal detachment is most commonly seen in patients with high myopia. The growing prevalence of high myopia is expected to contribute to segment growth. As per the WHO, the number of high myopes worldwide is expected to increase and reach 925 million in 2050 from 300 million in 2023. This is expected to increase the probability of retinal detachment, thus driving the need for vitrectomy.

The diabetic retinopathy segment is expected to grow at a significant rate during the forecast period. According to the American Academy of Ophthalmology, in 2019, worldwide, around 34.6% (93 million people) of diabetic adults aged 40 suffer from diabetic retinopathy.  Vitrectomy plays an important role in treating most ocular complications faced in diabetic retinopathy. These complications include severe fibrovascular proliferation, tractional or combined retinal detachment, non-clearing vitreous hemorrhage, tractional diabetic macular edema, and macular heterotopia.

End-use Insights

The hospital segment dominated the market and held the largest revenue share of around 43.0% in 2023, owing to the growing adoption of vitrectomy surgeries in these settings. A large number of hospitals are offering ophthalmic care, including vitrectomy, which, in turn, is expected to boost the installation of vitrectomy devices in them. For instance, in October 2015, a center of ocular oncology in Bengaluru installed a German-built vitrectomy machine along with a Pascal laser and electroretinogram (ERG), the MegaTRON S4 HPS, for the treatment of ocular and vitreoretinal oncology.

The ambulatory surgical centers (ASCs) segment is anticipated to grow at the fastest rate during the forecast period. The growing number of ASCs in developing countries is expected to contribute to the growth of the market. Additionally, increasing adoption of ophthalmic care in these settings due to reduced costs and shorter wait times is also expected to contribute towards the growth of the market. Moreover, the rapid treatment provided in the settings also adds to the advantage.

The ophthalmic clinic segment is also projected to show growth over the forecast period. A rising number of ocular disorders is expected to drive segment growth. Various ophthalmic professionals are opening clinics to meet the growing demand for ophthalmic care, thus contributing to segment growth.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 37.0% in 2023. The growing prevalence of ophthalmic disorders such as diabetic retinopathy, macular hole, retinal detachment, etc. is expected to contribute towards the growth of the market in the region. Additionally, the presence of a large number of market players in the U.S. is also expected to contribute to the same. These players are obtaining U.S. FDA clearance for their product, thus, maintaining their position in the North American market. For instance, in July 2021, Medical Instrument Development Laboratories, Inc. received FDA 510 (k) clearance for a bi-blade vitrectomy cutter.

In Asia Pacific, the market is expected to grow at the fastest rate of 6.4% during the forecast period. The presence of a large patient pool in the region seeking ophthalmic care is expected to drive the adoption of vitrectomy devices. Additionally, the growing focus of the government on providing enhanced medical facilities and proper care to patients may also contribute to market growth.

In Europe, the market for vitrectomy devices is expected to grow at a considerable rate. This can be attributed to the high prevalence of eye diseases, growing demand for technologically advanced products, and an increase in R&D investments for the development of new products. Carl Zeiss Meditec AG, a Germany-based player in the ophthalmic devices market, is highly focused on R&D to deliver innovative products in the European as well as the global market. During FY 2016–FY 2017, the company invested USD 164.7 million, or 12.3% of its total revenue, in R&D.

Some of the prominent players in the vitrectomy device market include:

• Alcon Inc.
• Bausch & Lomb Incorporated
• BVI
• NIDEK CO., LTD.
• Johnson & Johnson Vision Care, Inc.
• Blink Medical
• Topcon Corporation         
• Carl Zeiss Meditec AG
• Hoya Surgical Optics

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global vitrectomy device market.

Product

• Vitrectomy machines
• Vitrectomy packs
• Photocoagulation lasers
• Illumination devices

Application

• Diabetic retinopathy
• Retinal detachment
• Macular hole
• Vitreous hemorrhage
• Others

End-use

• Hospitals
• Ophthalmic clinics
• Ambulatory surgical centers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)